Alport syndrome (AS) is one of themost common types of inherited nephritis caused bymutation in one of the glomerular basement membrane components. AS is characterized by proteinuria at early stage of the disease and glomerular hyperplastic phenotype and renal fibrosis at late stage. Here, we show that global deficiency of tumor suppressor p53 significantly accelerated AS progression in X-linked AS mice and decreased the lifespan of these mice. p53 protein expression was detected in 21-week-old wild-typemice but not in age-matched AS mice. Expression of proinflammatory cytokines and profibrotic genes was higher in p53+/- AS mice than in p53+/+ AS mice. In vitro experiments revealed that p53 modulates podocyte migration and positively regulates the expression of podocyte-specific genes. We established podocyte-specific p53 (pod-p53)-deficient AS mice, and determined that pod-p53 deficiency enhanced the AS-induced renal dysfunction, foot process effacement, and alteration of gene-expression pattern in glomeruli. These results reveal a protective role of p53 in the progression of AS and in maintaining glomerular homeostasis by modulating the hyperplastic phenotype of podocytes in AS.
CITATION STYLE
Fukuda, R., Suico, M. A., Kai, Y., Omachi, K., Motomura, K., Koga, T., … Kai, H. (2016). Podocyte p53 Limits the Severity of Experimental Alport Syndrome. Journal of the American Society of Nephrology, 27(1), 144–157. https://doi.org/10.1681/ASN.2014111109
Mendeley helps you to discover research relevant for your work.